DEF 14A: Streamline Health Solutions Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals

Streamline Health Solutions announces its 2024 Annual Meeting of Stockholders to be held virtually on June 13, 2024, featuring proposals including director elections, executive compensation, auditor ratification, and approval of a new incentive plan.

Summary

• Streamline Health Solutions will hold its 2024 Annual Meeting of Stockholders virtually on June 13, 2024, at 10:00 a.m. Eastern Time.
• Stockholders of record as of April 15, 2024, are entitled to vote at the meeting.
• The meeting will address the election of seven directors, an advisory vote on executive compensation, ratification of FORVIS, LLP as the independent auditor, and approval of the 2024 Omnibus Incentive Compensation Plan.
• The board of directors recommends voting FOR all director nominees and FOR Proposals 2, 3, and 4.
• The company emphasizes the importance of stockholder participation and provides instructions for voting by proxy via the Internet, telephone, or mail.

Sentiment

Score: 7

Explanation: The document presents a balanced view, highlighting both positive strategic directions and past financial challenges. The focus on future growth and innovation contributes to a moderately positive outlook.

Positives

• The company is focused on driving innovation and growth in the hospital revenue cycle space.
• Streamline Health aims to deliver increased value to clients and investors through strategic investments and adaptation to the macro environment.
• The board of directors is actively engaged in corporate governance and risk management.
• The company offers a comprehensive employee benefits package.

Risks

• The company's financial performance in fiscal year 2023 did not meet the minimum bonus targets.
• The company implemented temporary base salary reductions for the executive team from November 2022 through October 2023.

Future Outlook

Streamline Health anticipates continued bookings momentum in fiscal year 2024, driven by shifts in the macro environment and investments in innovation, service, and growth teams.

Management Comments

• Streamline Health exited 2023 as a stronger, leaner and more agile organization capable of driving innovation and growth in the complex landscape of hospital revenue cycles.
• We are confident that shifts in the macro environment and the investments we have made in our innovation, service and growth teams will deliver continued bookings momentum in fiscal year 2024, and, as a result, we will deliver increased value to our clients and investors.

Industry Context

The document highlights Streamline Health's focus on addressing the challenges faced by health systems in getting accurately paid for clinical care, aligning with the broader industry trend of improving revenue cycle management through technology solutions.

Comparison to Industry Standards

• The document references a peer group of healthcare technology and software-as-a-service companies used for compensation benchmarking, including American Software, Inc., Optimize-Rx Corporation, and Phreesia, Inc.
• The company's compensation practices are designed to be conservative but competitive, aiming to attract and retain key executives in a competitive market for talent.

Management Changes

Related Party Transactions

• The Company entered into a Master Services Agreement (the MSA) with 180 Consulting, LLC (180 Consulting), pursuant to which 180 Consulting has provided and will continue to provide a variety of services including product management, internal systems platform integration and software engineering services, among others, through separate statements of work.
• While no related person has a direct or indirect material interest in this MSA or the related statements of work, individuals providing services to us under the MSA and statements of work may share workspace and administrative costs of operation with an entity affiliated with Mr. Green.
• Inclusive of the MSA executed with 180 Consulting are statements of work that provide for the Company to sublicense a software through 180 Consulting that is owned by 121G.
• This is a services agreement for access to software that assists the Company in implementing and integrating with our clients technology.
• The license agreement is designed such that there is no material financial benefit that accrues to 121G.
• 180 Consulting licenses the software from 121G at cost.

Stakeholder Impact

• Shareholders are encouraged to participate in the voting process to influence the company's direction.
• Executive officers' compensation is designed to align with the interests of shareholders.
• Employees are eligible for participation in the 2024 Omnibus Incentive Compensation Plan.
• The company's success in improving revenue cycle management benefits health systems and ultimately patients.

Next Steps

• Stockholders are urged to vote on the proposals outlined in the proxy statement.
• The company will proceed with the 2024 Annual Meeting of Stockholders on June 13, 2024.
• The Compensation Committee will consider multiple potential performance criteria including bookings, sales, and adjusted EBITDA, as well as successful completion of certain aspects of the Company's strategic objectives in awarding cash bonuses to executive officers for the fiscal year ending January 31, 2025.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Board of Directors, Executive Compensation, Director Election, FORVIS, 2024 Omnibus Incentive Compensation Plan, Revenue Cycle Management, Healthcare Technology